Demand for mental health tools and services skyrockets; SAMSHA crisis hotline reported 9 times the number of requests for mental health crisis support in March
In this new era, thousands of mental health professionals are looking for ways to stay engaged with patients and run their practice during the COVID-19 outbreak. To help you navigate this transition, Genomind offers an on-demand webinar that includes a panel of experts, hosted by our own Chief Medical Officer Dr. David Krause. Learn how to transition your practice to telepsychiatry, gain insights into the regulatory landscape, and how to continue to use Genomind’s Pharmacogenetic testing from home.
Recent government actions enable telepsychiatry
As the first company to offer direct-to-patient, at-home mental health pharmacogenetic testing, Genomind is helping patients and physicians gain actionable mental health insights without having to leave their homes
Latest agreement quadruples number of pharmacies in Albertsons Companies offering Genomind’s tests and services